Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Remuzzi

Showing results (441-450 of 894) with videos related to

Pageof 90
Sort By:
Lancet (London, England)|March 7, 2002
Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trialRaul Plata, Arturo Cornejo, Carla Arratia, et al.
Journal of the American Society of Nephrology : JASN|March 21, 2008
Role of remission clinics in the longitudinal treatment of CKDPiero Ruggenenti, Elena Perticucci, Paolo Cravedi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Computed tomography evaluation of autosomal dominant polycystic kidney disease progression: a progress reportLuca Antiga, Marina Piccinelli, Giorgio Fasolini, et al.
American Journal of Nephrology|August 31, 2011
Antiproteinuric effect of chemokine C-C motif ligand 2 inhibition in subjects with acute proliferative lupus nephritisAlessandro Ble, Marta Mosca, Giorgio Di Loreto, et al.
Journal of the American Society of Nephrology : JASN|October 7, 2004
Targeted deletion of angiotensin II type 1A receptor does not protect mice from progressive nephropathy of overload proteinuriaAriela Benigni, Daniela Corna, Carla Zoja, et al.
Clinical and Experimental Nephrology|July 26, 2017
Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120Gerald Schulman, Tomas Berl, Gerald J Beck, et al.
Arthritis and Rheumatism|May 1, 2007
Cyclin-dependent kinase inhibition limits glomerulonephritis and extends lifespan of mice with systemic lupusCarla Zoja, Federica Casiraghi, Sara Conti, et al.
BMC Nephrology|October 8, 2016
The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trialsGerald Schulman, Tomas Berl, Gerald J Beck, et al.
The New England Journal of Medicine|June 3, 2011
Early-childhood membranous nephropathy due to cationic bovine serum albuminHanna Debiec, Florence Lefeu, Markus J Kemper, et al.
Organogenesis|March 13, 2009
The KIDSTEM European Research Training Network: Developing a Stem Cell Based Therapy to Replace Nephrons Lost through Reflux NephropathyPatricia Murray, Giovanni Camussi, Jamie A Davies, et al.
Pageof 90

Showing results (441-450 of 894) with videos related to

Sort By:
Pageof 90
Lancet (London, England)|March 7, 2002
Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trialRaul Plata, Arturo Cornejo, Carla Arratia, et al.
Journal of the American Society of Nephrology : JASN|March 21, 2008
Role of remission clinics in the longitudinal treatment of CKDPiero Ruggenenti, Elena Perticucci, Paolo Cravedi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Computed tomography evaluation of autosomal dominant polycystic kidney disease progression: a progress reportLuca Antiga, Marina Piccinelli, Giorgio Fasolini, et al.
American Journal of Nephrology|August 31, 2011
Antiproteinuric effect of chemokine C-C motif ligand 2 inhibition in subjects with acute proliferative lupus nephritisAlessandro Ble, Marta Mosca, Giorgio Di Loreto, et al.
Journal of the American Society of Nephrology : JASN|October 7, 2004
Targeted deletion of angiotensin II type 1A receptor does not protect mice from progressive nephropathy of overload proteinuriaAriela Benigni, Daniela Corna, Carla Zoja, et al.
Clinical and Experimental Nephrology|July 26, 2017
Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120Gerald Schulman, Tomas Berl, Gerald J Beck, et al.
Arthritis and Rheumatism|May 1, 2007
Cyclin-dependent kinase inhibition limits glomerulonephritis and extends lifespan of mice with systemic lupusCarla Zoja, Federica Casiraghi, Sara Conti, et al.
BMC Nephrology|October 8, 2016
The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trialsGerald Schulman, Tomas Berl, Gerald J Beck, et al.
The New England Journal of Medicine|June 3, 2011
Early-childhood membranous nephropathy due to cationic bovine serum albuminHanna Debiec, Florence Lefeu, Markus J Kemper, et al.
Organogenesis|March 13, 2009
The KIDSTEM European Research Training Network: Developing a Stem Cell Based Therapy to Replace Nephrons Lost through Reflux NephropathyPatricia Murray, Giovanni Camussi, Jamie A Davies, et al.
Pageof 90